Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients

NCT03969017 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis of Liver Due to Hepatitis B (Disorder)

Interventions

DRUG: pegylated interferon (Peg IFN)α-2b
DRUG: Nucleoside （acid）analogue (NAs)

Sponsor

Sun Yat-sen University